APA (7th ed.) Citation

H, G., S, I., V, O. M., S, E., H, P., & P, S. (2021). Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations. Vaccine, 39(3), 580. https://doi.org/10.1016/j.vaccine.2020.12.003

Chicago Style (17th ed.) Citation

H, Greter, Ivol S, Oriol Mathieu V, Erismann S, Prytherch H, and Steinmann P. "Heterologous Vaccine Regimen: Stakeholder Acceptance and Implementation Considerations." Vaccine 39, no. 3 (2021): 580. https://doi.org/10.1016/j.vaccine.2020.12.003.

MLA (9th ed.) Citation

H, Greter, et al. "Heterologous Vaccine Regimen: Stakeholder Acceptance and Implementation Considerations." Vaccine, vol. 39, no. 3, 2021, p. 580, https://doi.org/10.1016/j.vaccine.2020.12.003.